Zymeworks Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Coherus Oncology.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. | |
Founding Date | Founding Date 2000 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Redwood City, US HQ Camarillo, US | |
Employees | Employees 1,488 | Employees 14736% decrease |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 85.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) |
Cost of goods | Cost of goods $166.9m (FY, 2025) | Cost of goods $13.8m (FY, 2025) |
Gross profit | Gross profit $488.5m (FY, 2025) | Gross profit $28.4m (FY, 2025) |
Net income | Net income ($136.2m) (FY, 2025) | Net income $168m (FY, 2025) |
Operating ⚠ | ||
Phase II Trials Products | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products 1 (FY, 2020) |
Phase III Trials Products | Phase III Trials Products 3 (FY, 2021) | Phase III Trials Products 1 (FY, 2020) |
Trials Products Approved | Trials Products Approved 3 (FY, 2021) | Trials Products Approved 1 (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Coherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View company